Kidney Transplant Market Predicted to Reach $7.34 Billion by 2028, Driven by Innovations and Rising Demand for Transplants
January 28, 2024 19:49 ET
|
Research and Markets
Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) -- The "Kidney Transplant Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global interest in the kidney transplant...
American Kidney Fund Announces April 30 as the First Annual APOL1-Mediated Kidney Disease (AMKD) Awareness Day
January 25, 2024 08:50 ET
|
American Kidney Fund
ROCKVILLE, Md., Jan. 25, 2024 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is proud to announce that April 30, 2024 will mark the nation’s first ever AMKD Awareness Day. Building on AKF’s...
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
January 04, 2024 16:40 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook
American Kidney Fund Hosts Fourth National Summit on Unknown Causes of Kidney Disease
December 05, 2023 08:34 ET
|
American Kidney Fund
ROCKVILLE, Md., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) will convene more than 100 medical leaders, patient advocates and academic and industry leaders for the fourth...
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023 18:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
American Kidney Fund Renews Calls for Early Diagnosis and Treatment of Chronic Kidney Disease in New Report
November 30, 2023 09:23 ET
|
American Kidney Fund
ROCKVILLE, Md., Nov. 30, 2023 (GLOBE NEWSWIRE) -- Today the American Kidney Fund (AKF) released a new report that urges policymakers and advocates to broadly support measures—including improved...
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
November 29, 2023 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
November 09, 2023 16:01 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
November 08, 2023 16:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
November 02, 2023 09:05 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation